Plain-English translation of NCT07910370 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether pulsed field ablation (PFA) can treat atrial fibrillation — a condition where your heart rhythm becomes irregular — more quickly and effectively than cryoballoon ablation, which is an existing freezing technique. Both treatments work by isolating the pulmonary veins in your heart, which often trigger the irregular heartbeats of atrial fibrillation. You would be randomly assigned to receive one of these two procedures, and the research team would compare how long each takes and how well each works over the next year.
Atrial fibrillation affects millions of people and can increase the risk of stroke and heart problems. While cryoballoon ablation is an established treatment, the new pulsed field ablation technique may be faster and allow patients to go home the same day, potentially reducing hospital burden and improving patient experience.
You likely qualify if…
You likely don't qualify if…
You would come to the hospital for your ablation procedure, where you'd be randomly assigned to receive either pulsed field ablation or cryoballoon ablation. The research team is testing whether the pulsed field technique can be done faster without compromising safety or effectiveness. After your procedure, you would have follow-up visits over 12 months to check your heart rhythm, monitor for any complications, and see how well the treatment worked for you.
AI-generated summary from trial data · Nov 4, 2026 · Not medical advice
Germany